You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cMET, INC280, food,

Showing 1 - 25 of 8,755
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

cMET Dysegulation Advanced Solid Tumors Trial in Worldwide (INC280)

Completed
  • cMET Dysegulation Advanced Solid Tumors
  • Indianapolis, Indiana
  • +16 more
Dec 16, 2020

Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

Terminated
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +18 more
Jul 20, 2022

NSCLC Trial in Worldwide (INC280 (capmatinib))

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • INC280 (capmatinib)
  • Long Beach, California
  • +95 more
Dec 29, 2022

Non Small Cell Lung Cancer Trial in Worldwide (EGF816, INC280, Nivolumab)

Terminated
Has Results
  • Non Small Cell Lung Cancer
  • Houston, Texas
  • +12 more
Jan 31, 2022

Advanced Solid Tumors Which Are cMET-dependent Trial in Worldwide (Capmatinib, Nazartinib, Gefitinib)

Recruiting
  • Advanced Solid Tumors Which Are cMET-dependent
  • Boston, Massachusetts
  • +12 more
Jan 27, 2023

cMET-dysregulated Advanced Solid Tumors Trial in Worldwide (INC280, Midazolam, Caffeine)

Completed
  • cMET-dysregulated Advanced Solid Tumors
  • Atlanta, Georgia
  • +11 more
Dec 8, 2020

cMET-dysregulated Advanced Solid Tumors Trial in Worldwide (INC280, digoxin, rosuvastatin)

Completed
  • cMET-dysregulated Advanced Solid Tumors
  • Atlanta, Georgia
  • +14 more
Dec 8, 2020

Hepatic Impairment Trial in United States (INC280)

Completed
  • Hepatic Impairment
  • Miami, Florida
  • +4 more
Dec 8, 2020

Malignant Non-small Cell Tumor of Lung Stage IV Trial in Boston (Capmatinib (INC280))

Completed
Has Results
  • Malignant Non-small Cell Neoplasm of Lung Stage IV
  • Capmatinib (INC280)
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 11, 2022

NSCLC Trial in Worldwide (INC280 single agent, erlotinib)

Terminated
  • Non-Small Cell Lung Cancer
  • Los Angeles, California
  • +31 more
Feb 20, 2020

Advanced Hepatocellular Carcinoma With c-MET Dysregulation Trial in Worldwide (INC280)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma With c-MET Dysregulation
  • Nanjing, Jiangsu, China
  • +7 more
Jan 12, 2023

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

NSCLC, NSCLC Stage IV, NSCLC Stage IIIB Trial (MYTX-011)

Not yet recruiting
  • NSCLC
  • +5 more
  • (no location specified)
Dec 7, 2022

NSCLC Trial in Worldwide (INC280, Gefitinib)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Woolloongabba, Queensland, Australia
  • +30 more
Mar 12, 2021

Advanced Hepatocellular Carcinoma Trial in Worldwide (PDR001, INC280)

Completed
  • Advanced Hepatocellular Carcinoma
  • Toronto, Ontario, Canada
  • +16 more
Jul 29, 2021

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Involvement of Gut Microbiota-brain Cross-talk in Loss of Eating

Recruiting
  • Obesity
    • Girona, Spain
      Institut d'Investigació Biomèdica de Girona (IDIBGI)
    Jan 11, 2023

    FoodImage 3 Free-Living

    Not yet recruiting
    • Waste Management
    • +3 more
    • Ad libitum data collection
    • (no location specified)
    Sep 7, 2023

    Food Insecurity, Dietary Quality, Behavioral Economics Trial (Behavioral economics-enhanced user interface)

    Not yet recruiting
    • Food Insecurity
    • +3 more
    • Behavioral economics-enhanced user interface
    • (no location specified)
    May 3, 2023

    Food Addiction Trial in Ann Arbor (Dietary change (low ultra-processed food), Dietary change (high ultra-processed food))

    Recruiting
    • Food Addiction
    • Dietary change (low ultra-processed food)
    • Dietary change (high ultra-processed food)
    • Ann Arbor, Michigan
      University of Michigan
    Sep 12, 2023

    Carcinoma, Non-Small-Cell Lung Cancer Trial (INC280)

    Withdrawn
    • Carcinoma
    • Non-Small-Cell Lung Cancer
    • (no location specified)
    Jul 24, 2018

    Food Allergy in Infants Trial in Shanghai (Bifidobacterium M-16V, allergy food avoidance)

    Not yet recruiting
    • Food Allergy in Infants
    • Bifidobacterium M-16V
    • allergy food avoidance
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiaotong University School of Medicine
    Aug 1, 2023

    Persistent Food Allergy on Nutritional Status of Food Allergy

    Completed
    • Food Allergy
    • Blood sample analysis
    • +3 more
    • Ljubljana, Slovenia
      Universitiy Medical center Ljubljana, division for Pediatrics
    Jun 29, 2023

    Non-Small-Cell Lung Cancer Trial in Worldwide (Amivantamab, Lazertinib, Carboplatin)

    Recruiting
    • Non-Small-Cell Lung Cancer
    • Duarte, California
    • +100 more
    Jan 31, 2023